615 related articles for article (PubMed ID: 32125093)
21. Prunella vulgaris L. attenuates experimental autoimmune thyroiditis by inducing indoleamine 2,3-dioxygenase 1 expression and regulatory T cell expansion.
Qiu H; Zhang J; Guo Q; Zhang Y; Zhong X
Biomed Pharmacother; 2020 Aug; 128():110288. PubMed ID: 32480225
[TBL] [Abstract][Full Text] [Related]
22. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival.
Souissi S; Ghedira R; Macherki Y; Ben-Haj-Ayed A; Gabbouj S; Remadi Y; Sfar I; Chadli Z; Aouam K; Hassine M; Bouaouina N; Zakhama A; Hassen E
Immun Inflamm Dis; 2022 Sep; 10(9):e690. PubMed ID: 36039641
[TBL] [Abstract][Full Text] [Related]
24. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.
Kiank C; Zeden JP; Drude S; Domanska G; Fusch G; Otten W; Schuett C
PLoS One; 2010 Jul; 5(7):e11825. PubMed ID: 20689575
[TBL] [Abstract][Full Text] [Related]
25. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.
Gupta NK; Thaker AI; Kanuri N; Riehl TE; Rowley CW; Stenson WF; Ciorba MA
Inflamm Bowel Dis; 2012 Jul; 18(7):1214-20. PubMed ID: 21823214
[TBL] [Abstract][Full Text] [Related]
26. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients.
Hascitha J; Priya R; Jayavelu S; Dhandapani H; Selvaluxmy G; Sunder Singh S; Rajkumar T
Clin Biochem; 2016 Aug; 49(12):919-24. PubMed ID: 27106797
[TBL] [Abstract][Full Text] [Related]
28. Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma.
Li S; Han X; Lyu N; Xie Q; Deng H; Mu L; Pan T; Huang X; Wang X; Shi Y; Zhao M
Cancer Sci; 2018 Dec; 109(12):3726-3736. PubMed ID: 30264546
[TBL] [Abstract][Full Text] [Related]
29. The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis.
Yu CP; Fu SF; Chen X; Ye J; Ye Y; Kong LD; Zhu Z
Cell Physiol Biochem; 2018; 49(1):134-143. PubMed ID: 30134237
[TBL] [Abstract][Full Text] [Related]
30. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
31. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
32. Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
Botticelli A; Cerbelli B; Lionetto L; Zizzari I; Salati M; Pisano A; Federica M; Simmaco M; Nuti M; Marchetti P
J Transl Med; 2018 Aug; 16(1):219. PubMed ID: 30081936
[TBL] [Abstract][Full Text] [Related]
33. Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
Kozuma Y; Takada K; Toyokawa G; Kohashi K; Shimokawa M; Hirai F; Tagawa T; Okamoto T; Oda Y; Maehara Y
Eur J Cancer; 2018 Sep; 101():20-29. PubMed ID: 30014971
[TBL] [Abstract][Full Text] [Related]
34. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
Suzuki Y; Suda T; Yokomura K; Suzuki M; Fujie M; Furuhashi K; Hahimoto D; Enomto N; Fujisawa T; Nakamura Y; Inui N; Nakano Y; Nakamura H; Chida K
J Infect; 2011 Sep; 63(3):215-22. PubMed ID: 21784100
[TBL] [Abstract][Full Text] [Related]
35. B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.
Grozdics E; Berta L; Bajnok A; Veres G; Ilisz I; Klivényi P; Rigó J; Vécsei L; Tulassay T; Toldi G
BMC Pregnancy Childbirth; 2014 Sep; 14():306. PubMed ID: 25189405
[TBL] [Abstract][Full Text] [Related]
36. Changes in Indoleamine 2,3-Dioxygenase 1 Expression and CD8+ Tumor-Infiltrating Lymphocytes after Neoadjuvant Chemoradiation Therapy and Prognostic Significance in Esophageal Squamous Cell Carcinoma.
Zhou S; Yang H; Zhang J; Wang J; Liang Z; Liu S; Li Y; Pan Y; Zhao L; Xi M
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):286-294. PubMed ID: 32004580
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance and immune correlates of FADD in penile squamous cell carcinoma.
Xue T; Yan R; Li Z; Guo S; Xiao X; Jin J; Jiang L; Ma H; Wu C; Liu T; Wei L; Xiong L; Zhou F; Yao K; Liu R; Han H
Virchows Arch; 2023 May; 482(5):869-878. PubMed ID: 36813950
[TBL] [Abstract][Full Text] [Related]
38. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.
Fujiwara Y; Kato S; Nesline MK; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Treat Rev; 2022 Nov; 110():102461. PubMed ID: 36058143
[TBL] [Abstract][Full Text] [Related]
39. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
Hu X; Chen M; Liu W; Li Y; Fu J
Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
[TBL] [Abstract][Full Text] [Related]
40. Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration.
Liu XQ; Lu K; Feng LL; Ding M; Gao JM; Ge XL; Wang X
Leuk Lymphoma; 2014 Feb; 55(2):405-14. PubMed ID: 23682557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
